Title : 1 Intraocular Penetration of Intravenous 2 Micafungin in Inflamed Human Eyes

4 Kiyofumi Mochizuki, MD, PhD, Akira Sawada, MD, PhD, Shinsuke Suemori, MD, PhD, 5 Hideaki Kawakami, MD, PhD, Yoshiaki Niwa, MD, PhD, Yuji Kondo, MD, PhD, Kiyofumi 6 Ohkusu, PhD, Noriaki Yamada, MD, Shinji Ogura, MD, PhD, Takashi Yaguchi, PhD, Kazuko 7 Nishimura, MD, PhD, Satoshi Kishino, PhD 8 9 Department of Ophthalmology, Gifu University Graduate School of Medicine, Gifu 10 Department of Ophthalmology, Gifu Municipal Hospital, Gifu 11 Department of Ophthalmology, Gifu Prefectural General Medical Center, Gifu 12 Department of Ophthalmology, Chuno Kosei Hospital, Seki 13 Department of Microbiology, Gifu University Graduate School of Medicine, Gifu 14 Department of Emergency & Disaster Medicine, Advanced Critical Care Center Gifu 15 University, Gifu 16 Medical Mycology Research Center, Chiba University, Chiba 17 Department of Microbiology, Dokkyo Medical University, Tochigi 18 Department of Medication Use Analysis and Clinical Research, Meiji Pharmaceutical 19 University, Tokyo 20 21 All correspondence to: Kiyofumi Mochizuki, MD, PhD, Gifu University Graduate School of 22 Medicine, 1-1 Yanagido, Gifu-shi 501-1194, Japan 23 Tel: +81-58-230-5287 Fax: +81-58-230-6289 24 E-mail: mochi-gif@umin.ac.jp 25 26 Word count for the abstract:75 27 Word count for the text: 1226 28 29 The authors have no proprietary or financial interest in any products used in this study. 30 None to declare 31 Copyright © 2013, American Society for Microbiology. All Rights Reserved. Antimicrob. Agents Chemother. doi:10.1128/AAC.02300-12 AAC Accepts, published online ahead of print on 20 May 2013

[1]  M. Venditti Clinical Aspects of Invasive Candidiasis , 2012, Drugs.

[2]  K. Ohkusu,et al.  Intraocular penetration of micafungin in patient with Candida albicans endophthalmitis. , 2011, Journal of Ocular Pharmacology and Therapeutics.

[3]  Ronald N. Jones,et al.  Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009). , 2011, Diagnostic microbiology and infectious disease.

[4]  N. Eltoukhy,et al.  Antifungal Distribution Into Cerebrospinal Fluid, Vitreous Humor, Bone, and Other Difficult Sites , 2010 .

[5]  W. Peetermans,et al.  Intraocular penetration of voriconazole and caspofungin in a patient with fungal endophthalmitis. , 2009, The Journal of antimicrobial chemotherapy.

[6]  S. Kocsubé,et al.  Infectious Keratitis Caused by Aspergillus tubingensis , 2009, Cornea.

[7]  M. Callegan,et al.  Bacillus cereus-induced permeability of the blood-ocular barrier during experimental endophthalmitis. , 2009, Investigative ophthalmology & visual science.

[8]  W. Mieler,et al.  Voriconazole in the treatment of fungal eye infections: a review of current literature , 2008, British Journal of Ophthalmology.

[9]  M. Spirn,et al.  Ocular candidiasis: a review , 2008, British Journal of Ophthalmology.

[10]  A. Kumar Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial , 2008 .

[11]  Guangming Chen,et al.  Ocular distribution of intravenously administered micafungin in rabbits , 2008, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[12]  D. Goldblum,et al.  Ocular penetration of caspofungin in a rabbit uveitis model , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[13]  J. Sobel,et al.  Micafungin: a new echinocandin. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  D. Andes,et al.  Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Y. Yamato,et al.  Tissue distribution after intravenous dosing of micafungin, an antifungal drug, to rats. , 2004, Biological & pharmaceutical bulletin.

[16]  S. Piscitelli,et al.  Compartmental Pharmacokinetics and Tissue Distribution of the Antifungal Echinocandin Lipopeptide Micafungin (FK463) in Rabbits , 2001, Antimicrobial Agents and Chemotherapy.

[17]  J. Alió,et al.  Detection and Identification of Fungal Pathogens by PCR and by ITS2 and 5.8S Ribosomal DNA Typing in Ocular Infections , 2001, Journal of Clinical Microbiology.

[18]  G. Jackson Infectious Diseases Society of America, Incorporated , 1971 .